Core Viewpoint - The public fund industry in China is entering a stage of high-quality development, guided by the "Action Plan for Promoting High-Quality Development of Public Funds" issued by the China Securities Regulatory Commission [1][3]. Group 1: Industry Development - The public fund industry has played a positive role in serving the real economy, promoting capital market reform, and meeting residents' wealth management needs, but faces issues such as insufficient functionality and uneven development [3]. - The "Action Plan" emphasizes a focus on investor interests, urging industry institutions to adopt a governance model centered on the best interests of investors throughout all operational management processes [3][4]. - The plan serves as a guiding document for the high-quality development of the public fund industry, outlining a long-term and systematic approach [3]. Group 2: Company Strategy - Ruiyuan Fund adheres to the principle of maximizing long-term benefits for its investors, which is the foundation of all its operations, from product design to investment returns [4][6]. - The company emphasizes value investment, which is believed to yield long-term returns and improve resource allocation efficiency in the market [4][7]. - Ruiyuan Fund is committed to building a comprehensive investment management capability, focusing on value investment and long-term strategies [7][8]. Group 3: Product and Market Approach - Ruiyuan Fund adopts a boutique product strategy, managing five public fund products by the end of 2025, including three equity mixed funds and one bond mixed fund, providing diversified options for investors [10]. - The company maintains a restrained management scale, controlling initial and short-term growth through various measures to encourage long-term investment [11]. - Ruiyuan Fund emphasizes investor education and support, conducting over 5,000 events to engage with investors and promote investment knowledge [12][13]. Group 4: Social Responsibility - Public funds bear the dual responsibility of serving the real economy and residents' financial needs, with a focus on maximizing long-term investor benefits [15]. - Ruiyuan Fund actively engages in social responsibility through its charity foundation, focusing on education, healthcare, and rural revitalization projects [15][16]. - The company has established the Ruiyuan Science and Technology Award to honor contributions in research and innovation, supporting high-quality development [16].

Recent Events - The most notable event in the public fund market is the "Debang Fund Incident," which highlights the phenomenon of rapid inflow of funds due to online influencers, significantly diluting the returns for existing fund shareholders. This has sparked widespread discussions on the compliance of fund marketing and liquidity management [2] Stock Performance - New fund issuance has increased, with 43 new funds scheduled for issuance from February 9 to the end of February, involving multiple fund companies such as Southern, Guangfa, and Yongying, indicating an active market supply of products [3] - The ETF market continues to expand, with the total scale of domestic ETFs expected to exceed 6 trillion yuan by the end of 2025, reflecting a 62% annual growth rate. The proportion of ETFs in the A-share circulating market has also significantly increased, indicating a growing preference for passive investment tools [3] - Notably, the Ruiyuan Growth Value Mixed Fund, managed by Fu Pengbo, has removed large subscription restrictions starting February 9, attracting market attention [3] Institutional Perspectives - Fund advisory institutions have been actively adjusting their portfolios to optimize asset allocation. Data shows that over 170 advisory portfolios made adjustments in January 2026, with a primary focus on increasing allocations to A-shares (especially undervalued value-type funds) and bond assets [4] - Some institutional views suggest that despite recent market adjustments, the equity premium rate remains near historical averages, providing a "valuation buffer" and maintaining an optimistic outlook for the year's performance [4]

Core Viewpoint - Ruiyuan Fund has completed a capital increase, raising its registered capital from 100 million yuan to 104.95 million yuan through a cash contribution of 4.95 million yuan from its employee stock ownership platform [1][4][5]. Group 1: Capital Increase Details - The capital increase was executed on February 10, with the actual controller Chen Guangming's shareholding adjusted to 47.5653% after the increase [1][5]. - The capital increase did not alter the existing shareholder structure, and the registration and company charter updates have been completed [1][4]. - The total contributions from existing shareholders include significant amounts from Chen Guangming (49.9198 million yuan, 47.5653%), Fu Pengbo (12 million yuan, 11.4340%), and Liu Guifang (7.2 million yuan, 6.8604%) among others [3][5]. Group 2: Fund Management and Outlook - As of the end of 2025, Ruiyuan Fund is projected to manage a public offering scale of 64.918 billion yuan, with six products, including five mixed funds totaling 45.709 billion yuan and one bond fund of 19.209 billion yuan [5]. - The Ruiyuan Growth Value Mixed Fund expresses optimism about the market, focusing on identifying new investment opportunities from companies with better-than-expected annual reports [6]. - The Ruiyuan Balanced Value Three-Year Holding Mixed Fund anticipates that equity assets will continue to offer more attractive returns compared to other asset classes, with potential static returns of around 5% and growth returns for leading companies possibly exceeding 10% [6].

Core Viewpoint - The report highlights significant changes in the investment strategies of Ruiyuan Fund's star fund managers, with notable adjustments in stock holdings and performance metrics for the fourth quarter of 2025. Group 1: Fund Performance and Adjustments - Ruiyuan Growth Value Mixed Fund experienced a net redemption of 136.2 million shares, marking the second-highest redemption in its history, with total net assets decreasing from 23.629 billion yuan to 21.087 billion yuan [3][4] - The fund's stock allocation increased slightly from 89.93% to 90.48%, while the proportion of Hong Kong stocks in the fund's net value decreased from 27.92% to 20.14% [3][4] - Ruiyuan Balanced Value Three-Year Holding Fund's stock allocation reached a three-year high of 90.66%, with a slight increase in the proportion of Hong Kong stocks to 41.99% [10] Group 2: Stock Holdings and Changes - The top ten holdings of Ruiyuan Growth Value Mixed Fund included New Yisheng, Shenghong Technology, and Ningde Times, with New Yisheng seeing a 22.73% reduction in holdings [4][5] - Ruiyuan Balanced Value Three-Year Holding Fund saw significant changes, with the re-entry of Midea Group into the top ten holdings and reductions in holdings of companies like Lixun Precision and China Ping An [10][12] - The fund managers noted a shift in focus towards sectors like photovoltaic and semiconductor high-end equipment manufacturing, while reducing exposure to companies with weak fundamentals [6][10] Group 3: Future Outlook and Strategy - The fund managers expressed optimism about the market, anticipating that the return on equity assets will remain attractive compared to other asset classes, with potential returns exceeding 10% for leading companies [11][13] - They plan to focus on companies with strong fundamentals and competitive advantages, particularly those expanding overseas, as this is expected to drive future growth [13][14] - The report indicates a structural market environment with limited risks of significant downturns, while opportunities for excess returns remain [8][13]

Core Viewpoint - The public fund industry in China is entering a stage of high-quality development, guided by the "Action Plan for Promoting High-Quality Development of Public Funds" issued by the China Securities Regulatory Commission [1][2]. Industry Overview - The public fund industry has played a positive role in serving the real economy, promoting capital market reform, and meeting residents' wealth management needs, but faces challenges such as insufficient functionality and uneven development [1]. - The "Action Plan" emphasizes a focus on investor interests, urging industry institutions to prioritize the best interests of investors throughout all operational management processes [1][2]. Company Strategy - Ruifeng Fund adheres to a value investment philosophy, aiming to maximize long-term benefits for its investors, and focuses on high-quality product offerings [2][3]. - The company emphasizes a long-term investment approach, asserting that value investing yields better long-term results compared to other strategies [3]. Investment Management - Ruifeng Fund is committed to enhancing its comprehensive investment management capabilities, aligning its culture and mechanisms with value investment practices [4]. - The company has established a research-driven investment style, focusing on in-depth fundamental research to invest in high-quality companies with a long-term perspective [3][4]. Product Strategy - The company adopts a boutique product strategy, managing five public fund products as of the end of 2025, including three equity mixed funds, one bond mixed fund, and one secondary bond fund [6]. - Ruifeng Fund maintains a disciplined approach to fund management, controlling initial and short-term growth through various measures to encourage long-term holding [6][7]. Investor Education and Support - The company emphasizes investor education and support, conducting over 5,000 events since 2019 to engage with investors and promote value investment principles [8]. - Ruifeng Fund has established a systematic approach to investor education, including partnerships with educational institutions and the creation of educational materials [8][9]. Social Responsibility - As a key institutional investor, the public fund industry is tasked with serving the real economy and residents' financial needs, with a focus on creating long-term value for investors [9][10]. - Ruifeng Fund actively engages in social responsibility initiatives through its charity foundation, focusing on education, healthcare, and rural revitalization projects [9].

Group 1 - The first batch of mutual fund mid-term reports for 2025 has been released, with several fund managers including Ruiyuan Fund, Galaxy Fund, Zhonggeng Fund, and Nanhua Fund disclosing their reports [1] - Ruiyuan Growth Value Mixed Fund, managed by Fu Pengbo, has hidden heavy holdings in stocks such as BQ Materials, Sunny Optical Technology, Guanghui Energy, Innovent Biologics, Alibaba-W, BYD, Dongshan Precision, Bluestar Technology, Su Da Weige, and Berthelot [1] - Galaxy Industrial Power Mixed Fund, managed by Zheng Weishan, maintains a focus on high-end manufacturing industries, with adjustments in industry allocation but still primarily invested in electronics, computers, power equipment, new energy, communications, and machinery [1] Group 2 - The hidden heavy holdings of Galaxy Industrial Power Mixed Fund include stocks like Shunluo Electronics, Zhongke Feimeng, Shengbang Co., Jianghai Co., and Zhichun Technology, with each stock's market value accounting for over 2% of the fund's net asset value as of the end of Q2 [1] - Liu Sheng, manager of Zhonggeng Value Navigation Mixed Fund, expresses optimism about equity assets, highlighting strong business growth attributes in sectors such as pharmaceuticals, new energy, and smart electric vehicles [1] - The innovative drug sector has shown a continuous industrial trend since Q2, although some signs of bubble formation have emerged in trading, yet there are still opportunities to select undervalued companies with improving core competitiveness [1]

Group 1 - Over 300 active equity funds established before 2021 have surpassed their 2021 peak net values since July 2023, indicating positive returns for investors who held since the peak [1][2] - The rebound in active equity funds is attributed to strategic investments in technology, innovative pharmaceuticals, and new consumer sectors by veteran fund managers [1][4] - Notable funds like the Fortune New Vitality Mixed Fund and Huabao Core Advantage Mixed Fund have shown significant recovery, with year-to-date gains of 29.86% and 37.47% respectively, reaching historical highs [2][3] Group 2 - The E Fund Healthcare Industry Mixed Fund has also capitalized on the structural market trends, with its net value surpassing the 2021 peak and reaching a new high of 4.691 yuan [3] - Veteran fund managers such as Fu Pengbo and Chen Peng have made notable comebacks, with their funds achieving substantial gains by focusing on emerging sectors [4] - The importance of adapting investment strategies to current market trends is emphasized, as the era of passive investment is over, requiring active engagement with new industries [5][6]

Group 1 - The core trend observed in the second quarter of 2025 is that many prominent fund managers are increasing their positions in the innovative drug sector, indicating a growing interest in this area [1] - Yongying Fund's Gao Nan reported that the total scale of the funds he manages reached 15.326 billion yuan, a significant increase of nearly 3.5 billion yuan compared to the end of the first quarter [2] - Several funds managed by Gao Nan achieved net value growth exceeding 10%, ranking among the top in their category, showcasing a dual increase in performance and scale [2] Group 2 - The top ten holdings of Gao Nan's flagship fund, Yongying Ruixin, saw significant adjustments, with new additions from the communication equipment sector and innovative drug companies [3] - Major new holdings include companies like ZTE and Innovent Biologics, while positions in BYD and Ninebot were exited [3][4] - The three main investment directions for Gao Nan's funds are communication (TMT), innovative drugs, and light manufacturing, reflecting a clear structural adjustment in response to market themes [4] Group 3 - Gao Nan emphasizes stock selection based on company growth potential and earnings realization, aiming to reduce industry concentration while capturing growth opportunities [5] - The Yongying Technology Driven Fund plans to increase exposure to the artificial intelligence supply chain and reallocate in defense and biomedicine sectors [5] - Gao Nan expresses cautious optimism for the second half of the year, noting improved liquidity conditions and a strong financial risk prevention system established by the government [5] Group 4 - Ruiyuan Fund's Fu Pengbo also significantly increased allocations to the pharmaceutical sector, particularly in innovative drugs, during the second quarter [6] - The Ruiyuan Growth Value Mixed Fund reached a scale of 18.666 billion yuan, with a net value growth rate of 5.80%, outperforming its benchmark by 4.13 percentage points [6][7] - Fu Pengbo's portfolio is heavily weighted towards electronics, internet technology, precision manufacturing, and pharmaceuticals, with a stock position exceeding 92% [7] Group 5 - Fu Pengbo's strategy involves increasing holdings in the pharmaceutical sector, covering innovative drugs and traditional medicine benefiting from AI, while reducing exposure to traditional energy companies [10] - He plans to closely monitor mid-year reports from listed companies and seek industries and companies with rising prosperity [11] - Both Gao Nan and Fu Pengbo share a focus on innovative drugs, providing investors with a reference point for market trends and industry movements [11]

Group 1 - Jianxin Fund plans to invest at least 180 million yuan in its equity public products, having already invested 173 million yuan from Q4 2024 to Q1 2025 [1] - Multiple Hong Kong Stock Connect ETFs have issued warnings about premium risks due to high trading activity during the market closure, with some ETFs experiencing daily turnover rates exceeding 900% [1] - QDII funds have significantly reduced their holdings in US stocks, reallocating to A-shares and Hong Kong stocks [1] Group 2 - Fund manager Ge Lan has reduced her stake in Xinlitai by 2.1673 million shares, as reported in the company's Q1 2025 report [2] - Fund manager Fu Pengbo has slightly increased his position in Furuide by 120,000 shares, according to the latest Q1 2025 report [2] - Fund manager Xiao Nan has increased the allocation to liquor stocks, viewing it as a high-yield bond with domestic demand upside [3] Group 3 - The market showed mixed performance with the Shanghai Composite Index up 0.25% and the Shenzhen Component down 0.36%, with a total trading volume of 1.09 trillion yuan [4] - Hong Kong innovative drug-related ETFs saw strong performance, with some rising by as much as 5.77% [4][5] - A report indicates that the pharmaceutical sector may attract market funds due to previous declines, with investment opportunities focusing on innovative and generic drugs, as well as medical devices and services [7] Group 4 - A new fund, the China Securities Index Free Cash Flow ETF, is set to launch, managed by Xu Rongman, with a performance benchmark based on the China Securities Index Free Cash Flow Index [8]